Bang, C.H. et al. 2024. Ustekinumab Demonstrates Lower Uveitis Risk in Moderate to Severe Psoriasis Patients Compared with Tumor Necrosis Factor-α Inhibitors. Acta Dermato-Venereologica. 104, (Sep. 2024), adv34206. DOI:https://doi.org/10.2340/actadv.v104.34206.